UCA is devoted to offering our patients the most up-to-date care and therapy for their urological conditions. Participating in clinical trials allows us to help determine new treatments and medications to better care for our patients and others. Our physicians and research coordinators have extensive knowledge and experience of clinical trials and patient safety is our primary goal.
If you are part of a research study and have an emergency, please contact the 24-hour emergency line at 205-445-0182.
Current Open Trials
We are now accepting patients for the following trials. Please review the description of the trial to be sure that you qualify. Please submit a contact form to let us know which study you are interested in.
- Active Surveillance
- Urine sample at confirmatory biopsy (repeat biopsy after initial diagnosis)
- Participants may be eligible for compensation for time and travel.
- Started on the medication Orgovyx within the last month
- Observational Trial
Interstitial Cystitis/Bladder Pain
Interstitial Cystitis/Bladder Pain
- Interstitial cystitis for 6 months
- Various options available
- Participants may be eligible for compensation for time and travel
Clinical Research FAQs
What is clinical research?
“Clinical research” is the broad term that includes the process by which any new medication or medical device becomes FDA approved. Without this approval, a company cannot market a product for human use in the US. The path to FDA approval begins with “lab” research. This is where the basic science of a drug is worked out. Today, this often involves computer modeling and very high-tech methods.
Once a drug show promise in the lab, it is tested in animals to make sure that it is both safe and has potential to work. If this test is passed, the drug moves into human testing. This part of the approval process is divided into three phases:
The drug is given to a small number of people to evaluate its safety, determine a safe dosage range, and identify side effects.
The drug is given to a larger number of people to see if it is effective and to further evaluate its safety. Safety remains the primary question and a drug must pass this “safety test” without question to move to the next phase.
The drug is given to a very large number of people to further study its effectiveness and side effects. Effectiveness is the main subject with safety still being important.
During the trial
Almost every clinical trial will consist of the following visits:
Screening Visit: The screening visit often occurs during one visit to the clinic but can last for a certain window of time that gives the study team enough time to assess your eligibility for participation.
Randomization Visit: This visit occurs once your eligibility to participate in the clinic trial is verified and your treatment begins.
General Study Visits: At these visits the study team will collect information from you about any changes in your medication or general health. Vitals, labs, EKG or other tests may be administered.
End of Study Visit: This visit establishes the safety and efficacy of the study medicine during your trial participation
Your Rights in a Clinical Trial
You have the right to:
- The very best care
- Ask questions and get answers at any time
- Know what other treatment options may be available to you
- Confidentiality and privacy – your personal identifiers will be removed from study documents
- Withdraw from a clinical trial at any time
People choose to participate in a clinical trial for many reasons:
- Participants may be compensated for time and travel, depending on the study
- Opportunity to benefit from new treatment options
- Play an active role in your care
- Contribute to saving lives in the future
- Quality care from top doctors and researchers
What to expect in a clinical trial?
At UCA, you, the patient, are the main focus of any clinical study – your rights, protection and safety are our top priority. Making sure all patients fully learn and understand their rights before any trial is key.
What is informed consent?
Informed consent is a process used by researchers to provide potential and enrolled participants with information about a clinical study. This information helps people decide whether they want to enroll or continue to participate in the study.
The informed consent process is intended to protect participants and should provide enough information for a person to understand the risks of, potential benefits of, and alternatives to the study. Participants may withdraw from a study at any time, even if the study is not over.
UCA Research Providers and Clinical Research Team
Our investigators bring extensive experience and knowledge to our clinical trials and to your treatment. The safety and wellbeing of our research patients is our primary concern. We pledge to closely monitor your health throughout the study and provide prompt, personal care.
Clinical Research Staff
Leigh Ann Geiger
Clinical Research Nurse
Interested in Sponsoring a Trial?
UCA has built a robust clinical research infrastructure over the past 35 years. We are committed to providing our research participants with a safe and enjoyable research experience while also providing our industry partners with clean, usable data.
A few highlights of our program:
- Large & diverse patient population
- We have been conducting clinical trials for more than 35 years
- 30 board certified Urologists / Urogynecologists / Oncologists physicians with sub specialists including oncology and radiation oncology
- 14 advanced practice providers
- Dedicated & experienced research team, all extensively credentialed in clinical research, including GCP training and IATA certification
- 24-hour on-call coordinator coverage
- Department specific standard operating procedures
- Protocol-specific source documents
- Fully equipped research dedicated CLIA waived laboratory, including a -80 and -20 freezer, lab-grade refrigerator and dry ice
- In-house 12 lead ECG machine and interpretation
- In-house radiology
- Temperature monitored and double locked IP storage
- Experience in a variety of EDC and IVRS/IWRS systems
- Firm commitment to rapid turn-around times for budgets, CTA’s and regulatory documents
If you are a Sponsor interested in working with us, please contact us via email at firstname.lastname@example.org.
We welcome the opportunity to discuss our site and how we might partner together!
A member of our experienced clinical research team will respond to you within 24 hours.
Areas of expertise:
- Bladder cancer
- Erectile dysfunction
- Urinary incontinence
- Prostate cancer
- Urinary tract infection
- Benign prostate hyperplasia
- Overactive bladder
- Interstitial cystitis
If you would like more information on our current clinical research studies, please contact the Urology Centers of Alabama Clinical Research Department at email@example.com. If you are part of a research study and have an emergency, please contact the 24-hour emergency line at 205-445-0182.